![]() |
市場調査レポート
商品コード
1504200
パルスオキシメーターの市場規模、シェア、予測、動向分析:コンポーネント、ポータビリティ、技術、年齢、エンドユーザー別-2031年までの世界予測Pulse Oximeter Market Size, Share, Forecast, & Trends Analysis by Component (Device, SPO2 Sensors) Portability (Handheld, Wearable, Fingertip) Technology (Connected, Conventional) Age (Adult, Pediatric) End User - Global Forecast to 2031 |
||||||
カスタマイズ可能
|
パルスオキシメーターの市場規模、シェア、予測、動向分析:コンポーネント、ポータビリティ、技術、年齢、エンドユーザー別-2031年までの世界予測 |
出版日: 2024年05月01日
発行: Meticulous Research
ページ情報: 英文 250 Pages
納期: 5~7営業日
|
パルスオキシメーター市場は、2024年から2031年にかけてCAGR 5.4%で、2031年には34億米ドルに達すると予測されます。
本レポートでは、包括的な一次調査および二次調査、市場シナリオの詳細な分析に基づき、業界の主要促進要因・制約・課題・機会を提供しています。この市場を牽引しているのは、入院患者数の増加、新生児スクリーニングにおけるパルスオキシメーターの使用、慢性閉塞性肺疾患(COPD)と喘息の罹患率の増加、OTCパルスオキシメーターの普及拡大です。
さらに、パルスオキシメーターの技術的進歩、ウェアラブルデバイスの採用増加、センサ技術の進歩は、この市場に大きな成長機会をもたらしています。しかし、OTCパルスオキシメーターに関連するデータ精度と信頼性の懸念と規制上の懸念が、この市場の成長を抑制する可能性があります。さらに、血中酸素濃度をモニタリングするためのモバイルベースの代替技術の出現は、この市場で事業を展開する企業にとって大きな課題となっています。
(*注:SWOT分析は主要5社のみ)
Pulse Oximeter Market Size, Share, Forecast, & Trends Analysis by Component (Device {Prescription, OTC}, SPO2 Sensors) Portability (Handheld, Wearable, Fingertip) Technology (Connected, Conventional) Age (Adult, Pediatric) End User-Global Forecast to 2031
The pulse oximeter market is projected to reach $3.40 billion by 2031, at a CAGR of 5.4% from 2024 to 2031.
Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides the key drivers, constraints, challenges, and opportunities of the industry. This market is driven by the rising number of hospitalizations, the use of pulse oximeters in newborn screening, the growing incidence of chronic obstructive pulmonary disorder (COPD) and asthma, and the growing penetration of OTC pulse oximeters.
Furthermore, technological advancements in pulse oximeters, increasing adoption of wearable devices, and advancements in sensor technologies provide a significant growth opportunity for this market. However, data accuracy & reliability concerns and regulatory concerns related to over the counter (OTC) pulse oximeters may restrain the growth of this market. Additionally, the emergence of alternative mobile-based technologies for monitoring blood oxygen levels poses a major challenge for the players operating in this market.
Among components, in 2024, the devices segment is expected to account for the larger share of 57% of the pulse oximeter market. The large share of this segment is attributed to factors such as the increasing penetration of OTC devices, the rising demand for home care, and the high prevalence of chronic lung disorders such as COPD. The emergence of remote patient monitoring and telemedicine has boosted the demand for home healthcare. The use of pulse oximeters allows patients to track their oxygen saturation levels at home without needing to visit a healthcare facility.
Among portability, in 2024, the handheld segment is expected to account for the largest share of the pulse oximeter market. The large share of the segment is mainly attributed to the high prevalence of respiratory diseases increasing the rate of hospital admissions. In December 2023, the CDC announced a Health Alert Network health advisory warning that low vaccination uptake, coupled with rising levels of respiratory diseases, could lead to more disease and potentially more severe disease, straining the healthcare system in the U.S. Handheld devices are used to monitor patient vitals in hospitals. Hence, rising hospital admissions are driving the demand for handheld pulse oximeter devices.
Among technologies, in 2024, the conventional pulse oximeters segment is expected to account for the larger share of the pulse oximeter market. The large share of the segment is attributed to the widespread use and availability of conventional pulse oximeters. The increasing burden of respiratory disorders is driving hospital admissions globally. Conventional pulse oximeters are widely used across healthcare settings due to their accuracy and ease of handling for medical professionals. Thus, the usage of conventional pulse oximeters is higher across both developed as well as developing countries.
Among age groups, in 2024, the pediatrics segment is expected to record a higher CAGR during the forecast period. The high growth of this segment is driven by the increasing cases of newborn diseases, growing awareness regarding the detection of disorders at the newborn stage, the increasing number of companies providing newborn and fetal screening, and the increasing use of non-invasive devices. In the case of newborns, inherited disorders can be identified through various tests, including pulse oximetry.
Among end users, in 2024, the hospitals & clinics segment is expected to account for the largest share of the pulse oximeter market. Pulse oximeter devices offer significant benefits for hospitals, such as prompt decision-making during emergencies and real-time data reporting and alerts, resulting in enhanced healthcare delivery. The growing burden of chronic respiratory diseases and the rising number of surgeries are increasing hospital admissions, supporting the segment's largest share.
An in-depth analysis of the geographical scenario of the pulse oximeter market provides detailed qualitative and quantitative insights for the five major geographies (North America, Europe, Asia-Pacific, the Middle East & Africa, and Latin America) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of 42% of the pulse oximeter market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America's large share is primarily attributed to the high prevalence of chronic diseases, the presence of advanced healthcare facilities, increasing digitalization in healthcare, and the presence of key market players.
The key players operating in the pulse oximeter market are Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies, Inc. (U.S.), Masimo Corporation (U.S.), Beurer GmbH (Germany), Nonin Medical, Inc. (U.S.), Nihon Kohden Corporation (Japan), Dragerwerk AG & Co. KGaA (Germany), ICU Medical, Inc. (U.S.), and Spacelabs Healthcare (a subsidiary of OSI Systems, Inc.) (U.S.).
Pulse Oximeter Market-by Component
Pulse Oximeter Market-by Portability
Pulse Oximeter Market-by Technology
Pulse Oximeter Market-by Age Group
Pulse Oximeter Market-by End User
(Other end users include long-term care facilities, fitness & wellness centers, and public facilities.)
Pulse Oximeter Market-by Geography
(*Note: SWOT analysis will be provided for the top 5 players only.)